Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$27.55 - $32.39 $214,173 - $251,799
-7,774 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$25.85 - $30.47 $158,227 - $186,506
-6,121 Reduced 44.05%
7,774 $227,000
Q4 2018

Feb 14, 2019

BUY
$25.76 - $34.03 $357,935 - $472,846
13,895 New
13,895 $394,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.14B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.